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T
he elimination of health disparities in the United
States is a national priority and overriding goal for
Healthy People 2010 (HP 2010). Surveillance of health
indicators among minority populations is essential to elim-
inating disparities. Surveillance is critical for program
planning, policy making, evaluating population-based
strategies, and tracking progress toward national and
state objectives.
The U.S. public health field has made steady progress in
diabetes surveillance over the past decade, but there is
much room for improvement (1). In this issue, Burrows et
al report the findings and recommendations of an expert
panel on the feasibility of using current surveys for dia-
betes surveillance among minority populations (2). The
expert panel, convened by the Division of Diabetes
Translation at the Centers for Disease Control and
Prevention, found existing surveys insufficient for dia-
betes survey surveillance among minority populations,
and, given the realities of finite resources, the panel rec-
ommended modifying and expanding existing survey sys-
tems to improve this capacity.
Many initiatives to eliminate racial and ethnic dispar-
ities are underway at the state and local levels; therefore,
surveillance systems are needed at these levels. In an
analysis of the capacity of states to measure HP 2010
objectives, Land found that only 56% of the objectives
could be measured at the state level and 33% at the coun-
ty level (3). At the state level, diabetes fared better than
most other focus areas (e.g., heart disease, cancer, envi-
ronmental health, immunization and infectious disease,
maternal and child health) because 12 of the 14 objec-
tives could be measured. However, if we extend this
analysis to race and ethnicity objectives, only 3 diabetes
mortality indicators are measurable. These HP 2010
measurable objectives are the framework for setting the
U.S. health agenda and for guiding state and local health
activities. Yet they cannot be used among minority popu-
lations at the state and local levels because they are not
currently measurable.
The Behavioral Risk Factor Surveillance System
(BRFSS) is a cornerstone of diabetes surveillance at the
state level. It is used for tracking the prevalence of dia-
betes, risk factors for diabetes and its complications (e.g.,
physical inactivity, obesity), and preventive care practices
among people with diabetes (e.g., adult vaccination, eye
exams). Of the surveys listed by Burrows et al, the BRFSS
is the only one conducted among all 50 states in a system-
atic, ongoing way. Unfortunately, the BRFSS remains
inadequate for diabetes surveillance among minority pop-
ulations. In 2000, the median state BRFSS sample size for
all persons diagnosed with diabetes was 211. Thus, few
states had sufficient respondents with diabetes to estimate
risk factors and preventive care practices among minority
populations with diabetes.
Another issue for states is the ability to establish long-
term resources to conduct and maintain health surveil-
lance among minority populations. For example, in 2001,
the Minnesota Department of Health (MDH) began a mul-
timillion-dollar initiative to eliminate health disparities:
diabetes was one of 8 health priority areas. Part of the
statute establishing the initiative specifies that "[t]he com-
missioner [of health] shall enhance current data tools to
ensure a statewide assessment of risk behaviors associat-
ed with the eight health disparity priority areas. The
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statewide assessment must be used to establish a baseline
to measure the effect of activities funded." This is an
important statement because it recognizes the need to
improve statewide surveillance among minority popula-
tions. But, despite the statutory requirement to improve
surveillance, the legislature mandated that all funds be
distributed in grants to communities and to the MDH for
oversight and programmatic support. No funds were made
available for statewide improvement in surveillance sys-
tems among minority populations.
Emerging minority populations within states, such as
the Somali and the Hmong in Minnesota, pose additional
diabetes surveillance challenges. Health surveillance
data on these populations are almost nonexistent.
Furthermore, new methods designed to overcome lan-
guage and cultural barriers may be required for identify-
ing and tracking diabetes indicators among these popula-
tions; traditional methods such as telephone surveys may
not be feasible.
In Minnesota, one approach used to identify appropri-
ate health indicators for surveillance is participatory
research partnerships (PRPs). This approach involves
partnerships among African American, African immi-
grant, American Indian, Hispanic, and Asian immigrant
communities to understand health concepts and other cul-
tural issues and to determine appropriate health indica-
tors. The challenge of systematically and regularly moni-
toring these health indicators remains.
At the state and local levels, expanding the BRFSS or
developing new surveys for diabetes surveillance among
minority communities will be costly. To expand diabetes
surveillance, states must look to alternatives such as
health care administrative data (e.g., hospital discharge,
Medicare, Medicaid, managed care). Even though such
data only pertain to people under medical care, analyzing
data already being collected may be the most efficient way
of expanding diabetes surveillance among minority popu-
lations.
Unfortunately, many hospitals and most managed care
organizations do not systematically collect or report race
and ethnicity information. The Institute of Medicine, in a
report on disparities in health care, has recommended
that race and ethnicity, education level, and primary lan-
guage data all be collected and reported in a standardized
way and included in hospital and managed care perform-
ance measurement (4). A pilot project among 8 managed
care organizations (MCOs) has begun exploring methods
for assessing racial and ethnic disparities within their
populations. Bierman et al have outlined the importance
of using race and ethnicity data by MCOs as well as high-
lighted potential barriers to collecting racial and ethnic
data — barriers such as perceived legal, business, and
confidentiality concerns (5,6).
In Minnesota, statutory language was developed to
require insurers to provide claims data — and eventual-
ly race and ethnicity data — to the MDH for the purpose
of public health research and surveillance. Public con-
cerns about data confidentiality curtailed this initiative,
even though sophisticated methods for ensuring confi-
dentiality were in place. The MDH continues to garner
support from health care providers, MCOs, and other
stakeholders and to articulate the purpose, need, and
confidentiality safeguards for a statewide medical claims
database. Such large-scale efforts, either voluntary or
statutory, are underway in many states and can consid-
erably enhance state and local diabetes surveillance
among minority populations.
Current state diabetes surveillance systems among
minority populations must be improved if we are to make
progress toward eliminating racial and ethnic disparities
or to know if we are even making progress. Expanding
current surveillance surveys, although less expensive
than starting new surveys, will require substantial finan-
cial resources and long-term commitment. For some pop-
ulations (recent immigrants, for example) new surveil-
lance methods may be required. The use of alternative
surveillance data sources, such as health care adminis-
trative data, will have financial ramifications and raise
confidentiality concerns. Ultimately, a concerted and com-
mitted effort by public health and health care organiza-
tions to begin systematically collecting and reporting data
on race and ethnicity is needed and will benefit all.
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